Lupin Wins US FDA Approval for Amifampridine Tablets
Lupin’s November 2 FDA approval for amifampridine adds a potential rare-disease growth catalyst, though commercial impact remains to be established.
Karyopharm Bankruptcy and Ayrmid Merger Put Pharma Restructuring in Focus
Karyopharm’s bankruptcy protection filing and planned merger with Ayrmid highlight the growing role of restructuring-driven M&A in biotech.
Trade with the conviction of the 1%.
Institutional-grade market intelligence delivered before the opening bell.
Axsome’s Q3 Update Gives AXSM Investors a Read on CNS Commercial Execution
Axsome’s third-quarter update gives AXSM investors a results-day lens on CNS commercial execution, pipeline momentum and…
uniQure’s QURE Shares Enter the Spotlight After FDA Grants Huntington’s Gene-Therapy Priority Review
FDA acceptance and Priority Review for uniQure’s Huntington’s gene-therapy application create a potentially important ca…
Karyopharm Bankruptcy and Ayrmid Merger Put Shareholder Recovery in Focus
Karyopharm’s bankruptcy filing and planned Ayrmid merger highlight creditor priority and uncertainty over any recovery f…
Vanda Revenue Climbs 24%, but Cash Burn Raises Liquidity Questions for VNDA Investors
Vanda’s Q3 revenue rose 24%, but a $123.4 million liquidity decline and higher expected cash burn complicate the Nasdaq-…
AbbVie Raises Full-Year Outlook After Q3 Beat as Skyrizi Pipeline Expands
AbbVie beat Q3 2026 estimates and raised its full-year outlook while advancing Skyrizi combinations and reporting positi…
AstraZeneca ADR Jumps 7% After Q3 Beat as Tagrisso and Baxfendy Drive Momentum
AstraZeneca's Nasdaq-listed ADR rose 7% after a Q3 beat, with Tagrisso sales and respiratory pipeline progress supportin…
Nasdaq Suffers Worst Month Since March 2025 as AI Costs and Fed Signals Pressure Tech
The Nasdaq endured its worst month since March 2025 as AI spending concerns and hawkish Fed commentary pressured technol…
Global Payments Jumps as CD&R Reportedly Pursues Takeover
Global Payments shares surged after Seeking Alpha reported that CD&R is pursuing a takeover, putting payments-sector M&A…
Inovio Stock Surges After FDA Clears First Product as Precigen Shares Sink
Inovio's first FDA approval triggered a sharp stock reaction, while Precigen shares fell as investors reassessed the RRP…